// App-Quantinova.ai

: Prevalence, clinical characteristics and outcomes of procedural complications of percutaneous coronary intervention in non ST-elevation myocardial infarction: insights from the TAO trial

Researchers

Presenter

  • J Abtan

Principal Investigators

  • E Sorbets

  • B Popovic

  • Y Elbez

  • S Mehta

  • M S Sabatine

  • S D Wiviott

  • C Bode

  • C V Pollack

  • M Cohen

Medical Centers

  • GH Bichat Claude Bernard, Paris, France

  • Hospital Avicenne of Bobigny, Cardiology, Bobigny, France

  • Hospital Brabois of Nancy, Vandoeuvre les Nancy, France

  • Brigham and Womens Hospital, Boston, MA, United States

  • University of Freiburg, Freiburg, Germany

  • Thomas Jefferson University Hospital, Philadelphia, United States of America

  • Newark Beth Israel Medical Center, Newark, NJ, United States.

Locations

  • France

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

  • eptifibatide

  • Otamixaban

  • Heparin

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Multinational

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved